Background: The brain is critically dependent on uninterrupted blood flow for the supply of nutrients and clearance of metabolites.
Both an increase and decrease in the blood flow are harmful to the brain. Aim: This study aimed to evaluate the effectiveness of
Dexmedetomidine (in comparison to normal saline) in maintaining haemodynamic parameters during laryngoscopy among
patients undergoing elective intracranial surgery. Material and methods: This was a single centre, parallel-group, 1:1, and singleblind, placebo-controlled, randomised control study. 60 patients undergoing elective neurosurgery were randomised to intravenous
dexmedetomidine (0.4mcg/kg/hr) or a similar volume of normal saline. Following outcomes were measured: heart rate, mean
arterial pressure (MAP), the dose of thiopentone, time to extubation, and level of sedation. Results: The time for extubation in the
Group D group was 5.23 minutes and in the Group C group, it was 8.6 minutes (p<0.0001). At endline, the sedation score among
participants in group D was less in comparison to participants in group C. The mean dose of thiopentone required in group D
participants was significantly less than those required by participants in group C (p<0.0001). Dexmedetomidine effectively blunted
the increase in heart rate and mean arterial pressure both at intubation and extubation. There was a difference of 21% point between
the MAP values between group D and group C participants at intubation. Conclusion: Dexmedetomidine has an anaesthetic sparing
effect, and it reduced the time of recovery among patients undergoing neurosurgery.
Keywords: Laryngoscopy, Intubation, Dexmedetomidine, Neurosurgery